Preliminary scientific studies show conolidine may inhibit distinct ion channels, lessening neuronal excitability and restricting suffering indicators. This system is especially pertinent in neuropathic suffering, where irregular signaling brings about persistent pain. In addition, conolidine appears to impact G protein-coupled receptor (GPCR) path